Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

C/EBPγ deregulation results in differentiation arrest in acute myeloid leukemia
Meritxell Alberich-Jordà, … , Ruud Delwel, Daniel G. Tenen
Meritxell Alberich-Jordà, … , Ruud Delwel, Daniel G. Tenen
Published November 19, 2012
Citation Information: J Clin Invest. 2012;122(12):4490-4504. https://doi.org/10.1172/JCI65102.
View: Text | PDF | Corrigendum
Research Article Oncology Article has an altmetric score of 11

C/EBPγ deregulation results in differentiation arrest in acute myeloid leukemia

  • Text
  • PDF
Abstract

C/EBPs are a family of transcription factors that regulate growth control and differentiation of various tissues. We found that C/EBPγ is highly upregulated in a subset of acute myeloid leukemia (AML) samples characterized by C/EBPα hypermethylation/silencing. Similarly, C/EBPγ was upregulated in murine hematopoietic stem/progenitor cells lacking C/EBPα, as C/EBPα mediates C/EBPγ suppression. Studies in myeloid cells demonstrated that CEBPG overexpression blocked neutrophilic differentiation. Further, downregulation of Cebpg in murine Cebpa-deficient stem/progenitor cells or in human CEBPA-silenced AML samples restored granulocytic differentiation. In addition, treatment of these leukemias with demethylating agents restored the C/EBPα-C/EBPγ balance and upregulated the expression of myeloid differentiation markers. Our results indicate that C/EBPγ mediates the myeloid differentiation arrest induced by C/EBPα deficiency and that targeting the C/EBPα-C/EBPγ axis rescues neutrophilic differentiation in this unique subset of AMLs.

Authors

Meritxell Alberich-Jordà, Bas Wouters, Martin Balastik, Clara Shapiro-Koss, Hong Zhang, Annalisa DiRuscio, Hanna S. Radomska, Alexander K. Ebralidze, Giovanni Amabile, Min Ye, Junyan Zhang, Irene Lowers, Roberto Avellino, Ari Melnick, Maria E. Figueroa, Peter J.M. Valk, Ruud Delwel, Daniel G. Tenen

×

Total citations by year

Year: 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2009 Total
Citations: 4 2 3 4 2 2 4 5 5 6 3 3 1 44
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (44)

Title and authors Publication Year
Human RP105 monoclonal antibody enables the production of antigen-specific antibody
Tatsuya Yamazaki, Kenta Iwasaki, Susumu Tomono, Masaki Imai, Yuko Miwa, Masato Shizuku, Satoshi Ashimine, Kohei Ishiyama, Masanori Inui, Daisuke Okuzaki, Takaaki Kobayashi, Sachiko Akashi-Takamura
iScience 2024
C/EBPα-p30 confers AML cell susceptibility to the terminal unfolded protein response and resistance to Venetoclax by activating DDIT3 transcription
Du M, Wang M, Liu M, Fu S, Lin Y, Huo Y, Yu J, Yu X, Wang C, Xiao H, Wang L
Journal of experimental & clinical cancer research : CR 2024
CEBPA mutations in acute myeloid leukemia: implications in risk stratification and treatment.
Tien FM, Hou HA
International Journal of Hematology 2024
A comprehensive analysis of CEBPA on prognosis and function in uterine corpus endometrial carcinoma.
Wang J, Huang W, Chai S, Gan J, Zeng Y, Long P, Pang L
Scientific reports 2024
CEBPG suppresses ferroptosis through transcriptional control of SLC7A11 in ovarian cancer.
Zhang X, Zheng X, Ying X, Xie W, Yin Y, Wang X
Journal of Translational Medicine 2023
Homodimer-mediated phosphorylation of C/EBPα-p42 S16 modulates acute myeloid leukaemia differentiation through liquid-liquid phase separation
Wang D, Sun T, Xia Y, Zhao Z, Sheng X, Li S, Ma Y, Li M, Su X, Zhang F, Li P, Ma D, Ye J, Lu F, Ji C
Nature Communications 2023
CCAAT Enhancer Binding Protein Gamma (C/EBP-γ): an understudied transcription factor
Renfro Z, White BE, Stephens KE
Advances in Biological Regulation 2022
Small Extracellular Vesicles and Their Involvement in Cancer Resistance: An Up-to-Date Review.
Słomka A, Kornek M, Cho WC
Cells 2022
Mechanisms of myeloid leukemogenesis: Current perspectives and therapeutic objectives
Bouligny IM, Maher KR, Grant S
Blood Reviews 2022
CEBPγ facilitates lamellipodia formation and cancer cell migration through CERS6 upregulation
H Shi, A Niimi, T Takeuchi, K Shiogama, Y Mizutani, T Kajino, K Inada, T Hase, T Hatta, H Shibata, T Fukui, TF ChenYoshikawa, K Nagano, T Murate, Y Kawamoto, S Tomida, T Takahashi, M Suzuki
Cancer Science 2021
CRED9: a differentially expressed elncRNA regulates expression of transcription factor CEBPA
RL Setten, P Chomchan, EW Epps, JC Burnett, JJ Rossi
RNA (New York, N.Y.) 2021
CEBPG promotes acute myeloid leukemia progression by enhancing EIF4EBP1
Y Jiang, SY Wu, YL Chen, ZM Zhang, YF Tao, Y Xie, XM Liao, XL Li, Li, D Wu, HR Wang, R Zuo, HB Cao, JJ Pan, JJ Yu, SQ Jia, Z Zhang, XR Chu, YP Zhang, C Feng, JW Wang, SY Hu, ZH Li, J Pan, F Fang, J Lu
Cancer Cell International 2021
An Unfolded Protein Response Related Signature Could Robustly Predict Survival Outcomes and Closely Correlate With Response to Immunotherapy and Chemotherapy in Bladder Cancer
F Zhang, D Feng, X Wang, Y Gu, Z Shen, Y Yang, J Wang, Q Zhong, D Li, H Hu, P Han
Frontiers in Molecular Biosciences 2021
Activating transcription factor 3 coordinates differentiation of cardiac and hematopoietic progenitors by regulating glucose metabolism
HM Yin, LF Yan, Q Liu, Z Peng, CY Zhang, Y Xia, D Su, AH Gu, Y Zhou
Science Advances 2020
Circulating exosomal circFoxp1 confers cisplatin resistance in epithelial ovarian cancer cells
Y Luo, R Gui
Journal of Gynecologic Oncology 2020
Mutant CEBPA directly drives the expression of the targetable tumor-promoting factor CD73 in AML
JS Jakobsen, LG Laursen, MB Schuster, S Pundhir, E Schoof, Y Ge, T dAltri, K Vitting-Seerup, N Rapin, C Gentil, J Jendholm, K Theilgaard-Mönch, K Reckzeh, L Bullinger, K Döhner, P Hokland, J Fitzgibbon, BT Porse
Science Advances 2019
Neutrophil Maturity in Cancer
JB Mackey, SB Coffelt, LM Carlin
Frontiers in immunology 2019
C/EBPγ is dispensable for steady-state and emergency granulopoiesis
M Kardosova, P Zjablovskaja, P Danek, P Angelisova, LL de Figueiredo-Pontes, RS Welner, T Brdicka, S Lee, DG Tenen, M Alberich-Jorda
Haematologica 2018
Progression from the Common Lymphoid Progenitor to B/Myeloid PreproB and ProB Precursors during B Lymphopoiesis Requires C/EBPα
H Guo, T Barberi, R Suresh, AD Friedman
Journal of immunology (Baltimore, Md. : 1950) 2018
Identification of cancer omics commonality and difference via community fusion: Cancer omics commonality and difference via community fusion
Y Sun, Y Jiang, Y Li, S Ma
Statistics in Medicine 2018
Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells
P Zjablovskaja, P Danek, M Kardosova, M Alberich-Jorda
Journal of visualized experiments : JoVE 2018
Disruption of the C/EBPα—miR-182 balance impairs granulocytic differentiation
AA Wurm, P Zjablovskaja, M Kardosova, D Gerloff, D Bräuer-Hartmann, C Katzerke, JU Hartmann, T Benoukraf, S Fricke, N Hilger, AM Müller, M Bill, S Schwind, DG Tenen, D Niederwieser, M Alberich-Jorda, G Behre
Nature Communications 2017
EVI2B is a C/EBPα target gene required for granulocytic differentiation and functionality of hematopoietic progenitors
P Zjablovskaja, M Kardosova, P Danek, P Angelisova, T Benoukraf, AA Wurm, T Kalina, S Sian, M Balastik, R Delwel, T Brdicka, DG Tenen, G Behre, F Fiore, B Malissen, V Horejsi, M Alberich-Jorda
Cell Death and Differentiation 2017
AMPA-receptor specific biogenesis complexes control synaptic transmission and intellectual ability
A Brechet, R Buchert, J Schwenk, S Boudkkazi, G Zolles, K Siquier-Pernet, I Schaber, W Bildl, A Saadi, C Bole-Feysot, P Nitschke, A Reis, H Sticht, N Al-Sannaa, A Rolfs, A Kulik, U Schulte, L Colleaux, RA Jamra, B Fakler
Nature Communications 2017
5azadC treatment upregulates miR-375 level and represses HPV16 E6 expression
A Morel, A Baguet, J Perrard, C Demeret, E Jacquin, D Guenat, C Mougin, JL Prétet
Oncotarget 2017
ZNF143 protein is an important regulator of the myeloid transcription factor C/EBPα
D Gonzalez, A Luyten, B Bartholdy, Q Zhou, M Kardosova, A Ebralidze, KD Swanson, HS Radomska, P Zhang, SS Kobayashi, RS Welner, E Levantini, U Steidl, G Chong, S Collombet, MH Choi, AD Friedman, LM Scott, M Alberich-Jorda, DG Tenen
The Journal of biological chemistry 2017
Transactivation of Sytl1/Slp1 by Meis1 promotes CXCL12/CXCR4 signaling and leukemogenesis
Takashi Yokoyama, Mayuka Nakatake, Takeshi Kuwata, Arnaud Couzinet, Ryo Goitsuka, Shuichi Tsutsumi, Hiroyuki Aburatani, Peter Valk, Ruud Delwel, Takuro Nakamura
Journal of Clinical Investigation 2016
CREB engages C/EBPδ to initiate leukemogenesis
C Tregnago, E Manara, M Zampini, V Bisio, C Borga, S Bresolin, S Aveic, G Germano, G Basso, M Pigazzi
Leukemia 2016
An autonomous CEBPA enhancer specific for myeloid-lineage priming and neutrophilic differentiation
R Avellino, M Havermans, C Erpelinck, MA Sanders, R Hoogenboezem, HJ van de Werken, E Rombouts, K Lom, PM van Strien, C Gebhard, M Rehli, J Pimanda, D Beck, S Erkeland, T Kuiken, H Looper, S Groschel, I Touw, E Bindels, R Delwel
Blood 2016
In Vivo Deletion of the Cebpa +37 kb Enhancer Markedly Reduces Cebpa mRNA in Myeloid Progenitors but Not in Non-Hematopoietic Tissues to Impair Granulopoiesis
H Guo, S Cooper, AD Friedman, T Akagi
PloS one 2016
The human nucleophosmin 1 mutation A inhibits myeloid differentiation of leukemia cells by modulating miR-10b
Q Zou, S Tan, Z Yang, J Wang, J Xian, S Zhang, H Jin, L Yang, L Wang, L Zhang
Oncotarget 2016
Pharmacological inhibition of fatty acid oxidation synergistically enhances the effect of L-asparaginase in childhood ALL cells
I Heřmanová, A Arruabarrena-Aristorena, K Vališ, H Nůsková, MA Jorda, K Fišer, S Fernández-Ruiz, D Kavan, A Pecinová, M Niso-Santano, M Žaliová, P Novák, J Houštěk, T Mráček, G Kroemer, A Carracedo, J Trka, J Starková
Leukemia 2015
C/EBPα in normal and malignant myelopoiesis
AD Friedman
International Journal of Hematology 2015
The +37 kb Cebpa Enhancer Is Critical for Cebpa Myeloid Gene Expression and Contains Functional Sites that Bind SCL, GATA2, C/EBPα, PU.1, and Additional Ets Factors
S Cooper, H Guo, AD Friedman, T Langmann
PloS one 2015
CEBPA methylation and mutation in myelodysplastic syndrome
X Wen, J Hu, J Yang, W Qian, D Yao, Z Deng, Y Zhang, X Zhu, H Guo, J Lin, J Qian
Medical Oncology 2015
C/EBPγ Is a Critical Regulator of Cellular Stress Response Networks through Heterodimerization with ATF4
CJ Huggins, MK Mayekar, N Martin, KL Saylor, M Gonit, P Jailwala, M Kasoji, DC Haines, OA Quiñones, PF Johnson
Molecular and cellular biology 2015
The multifaceted functions of C/EBPα in normal and malignant haematopoiesis
E Ohlsson, MB Schuster, M Hasemann, BT Porse
Leukemia 2015
Granulopoiesis requires increased C/EBPα compared to monopoiesis, correlated with elevated Cebpa in immature G-CSF receptor versus M-CSF receptor expressing cells
O Ma, SH Hong, H Guo, G Ghiaur, AD Friedman
PloS one 2014
Gene network-based analysis identifies two potential subtypes of small intestinal neuroendocrine tumors
M Kidd, IM Modlin, I Drozdov
BMC Genomics 2014
Genome-Scale CRISPR-Mediated Control of Gene Repression and Activation
LA Gilbert, MA Horlbeck, B Adamson, JE Villalta, Y Chen, EH Whitehead, C Guimaraes, B Panning, HL Ploegh, MC Bassik, LS Qi, M Kampmann, JS Weissman
Cell 2014
Sox4 Is a Key Oncogenic Target in C/EBPα Mutant Acute Myeloid Leukemia
H Zhang, M Alberich-Jorda, G Amabile, H Yang, PB Staber, AD Ruscio, RS Welner, A Ebralidze, J Zhang, E Levantini, V Lefebvre, PJ Valk, R Delwel, M Hoogenkamp, C Nerlov, J Cammenga, B Saez, DT Scadden, C Bonifer, M Ye, DG Tenen
Cancer Cell 2013
CEBPA-CEBPG axis as a novel promising therapeutic target in acute myeloid leukemia
Y Lou
Acta Pharmacologica Sinica 2013
C/EBPγ suppresses senescence and inflammatory gene expression by heterodimerizing with C/EBPβ
CJ Huggins, R Malik, S Lee, J Salotti, S Thomas, N Martin, OA Quiñones, WG Alvord, ME Olanich, JR Keller, PF Johnson
Molecular and cellular biology 2013
Pulmonary surfactant: an immunological perspective
ZC Chroneos, Z Sever-Chroneos, VL Shepherd
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 2009

← Previous 1 2 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Picked up by 1 news outlets
Posted by 2 X users
On 1 Facebook pages
71 readers on Mendeley
See more details